Sunday, April 5, 2009

Taro Receives Final FDA Approval for Carbamazepine Extended-Release Tablets

Apr 3, 2009 - Taro Pharmaceutical Industries Ltd. today reported that it received final approval from the U.S. FDA for its Abbreviated New Drug Application for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg.

The details can be read here.

No comments: